AdaptHealth Corp. (NASDAQ:AHCO) Receives $13.40 Average PT from Analysts

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have earned a consensus rating of “Hold” from the seven research firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating and five have given a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $13.40.

A number of equities analysts have commented on AHCO shares. Zacks Research downgraded AdaptHealth from a “hold” rating to a “strong sell” rating in a research note on Friday, September 19th. Wall Street Zen raised AdaptHealth from a “buy” rating to a “strong-buy” rating in a report on Sunday, October 19th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of AdaptHealth in a report on Friday.

Insider Transactions at AdaptHealth

In other news, Director David Solomon Williams III sold 8,200 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the sale, the director directly owned 50,045 shares of the company’s stock, valued at $486,937.85. This trade represents a 14.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.55% of the company’s stock.

Institutional Trading of AdaptHealth

Hedge funds have recently modified their holdings of the business. Reinhart Partners LLC. raised its holdings in shares of AdaptHealth by 1.1% during the second quarter. Reinhart Partners LLC. now owns 7,312,626 shares of the company’s stock worth $68,958,000 after acquiring an additional 76,364 shares in the last quarter. Palisade Capital Management LP raised its holdings in AdaptHealth by 12.3% during the first quarter. Palisade Capital Management LP now owns 2,711,142 shares of the company’s stock valued at $29,389,000 after buying an additional 297,268 shares in the last quarter. Invesco Ltd. raised its holdings in AdaptHealth by 50.0% during the second quarter. Invesco Ltd. now owns 1,906,074 shares of the company’s stock valued at $17,974,000 after buying an additional 634,973 shares in the last quarter. Iron Triangle Partners LP bought a new position in AdaptHealth during the first quarter valued at about $17,496,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in AdaptHealth by 14.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,301,652 shares of the company’s stock valued at $14,110,000 after buying an additional 163,272 shares in the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Trading Up 1.5%

NASDAQ:AHCO opened at $9.37 on Thursday. The business’s 50-day moving average is $9.17 and its two-hundred day moving average is $9.00. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.06 and a quick ratio of 0.82. AdaptHealth has a 12 month low of $7.11 and a 12 month high of $11.63. The firm has a market capitalization of $1.27 billion, a PE ratio of 17.35, a price-to-earnings-growth ratio of 1.16 and a beta of 1.61.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.